CASI PHARMACEUTICALS, INC. Finite-Lived Intangible Assets, Accumulated Amortization
CASI PHARMACEUTICALS, INC. (CASIF) had Finite-Lived Intangible Assets, Accumulated Amortization of $1.55 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-05-15
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $1.55M.
- 2024-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $1.52M.
- 2023-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $463.00K.
- 2022-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $6.29M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2025-12-31 | $1.55M 20-F · filed 2026-05-15 |
| 2024-12-31 | $1.52M 20-F · filed 2026-05-15 |
| 2023-12-31 | $463.00K 20-F · filed 2025-03-31 |
| 2022-12-31 | $6.29M 20-F · filed 2024-03-28 |
| 2021-12-31 | $3.83M 20-F · filed 2023-04-26 |